Home  »  Companies   »  Why Nuvation Bio Inc. (NUVB)’s Most Recent Repor...

Why Nuvation Bio Inc. (NUVB)’s Most Recent Report Reveals Some Hints About Its Future

Nuvation Bio Inc. (NYSE:NUVB) went up by 1.10% from its latest closing price compared to the recent 1-year high of $10.45. The company’s stock price has collected -4.66% of loss in the last five trading sessions.

Is It Worth Investing in Nuvation Bio Inc. (NYSE :NUVB) Right Now?

Opinions of the stock are interesting as 5 analysts out of 7 who provided ratings for Nuvation Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The average price from analysts is $4.60, which is $2.76 above the current price. NUVB currently public float of 159.62M and currently shorts hold a 3.09% ratio of that float. Today, the average trading volume of NUVB was 617.31K shares.

NUVB’s Market Performance

NUVB stocks went down by -4.66% for the week, with a monthly drop of -14.42% and a quarterly performance of -38.46%, while its annual performance rate touched -80.11%. The volatility ratio for the week stands at 5.00% while the volatility levels for the past 30 days are set at 5.94% for Nuvation Bio Inc. The simple moving average for the period of the last 20 days is -9.52% for NUVB stocks with a simple moving average of -49.22% for the last 200 days.

Analysts’ Opinion of NUVB

BMO Capital Markets, on the other hand, stated in their research note that they expect to see NUVB reach a price target of $2.50, previously predicting the price at $8. The rating they have provided for NUVB stocks is “Market Perform” according to the report published on August 02nd, 2022.

H.C. Wainwright gave a rating of “Buy” to NUVB, setting the target price at $14 in the report published on May 04th of the current year.

NUVB Trading at -14.26% from the 50-Day Moving Average

After a stumble in the market that brought NUVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.39% of loss for the given period.

Volatility was left at 5.94%, however, over the last 30 days, the volatility rate increased by 5.00%, as shares sank -14.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.69% lower at present.

During the last 5 trading sessions, NUVB fell by -4.66%, which changed the moving average for the period of 200-days by -68.28% in comparison to the 20-day moving average, which settled at $2.0175. In addition, Nuvation Bio Inc. saw -78.35% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at NUVB starting from Omega Fund V, L.P., who sale 2,500,000 shares at the price of $5.60 back on Apr 05. After this action, Omega Fund V, L.P. now owns 20,457,340 shares of Nuvation Bio Inc., valued at $14,000,000 using the latest closing price.

Omega Fund V, L.P., the 10% Owner of Nuvation Bio Inc., sale 500,000 shares at $10.07 during a trade that took place back on Dec 15, which means that Omega Fund V, L.P. is holding 22,957,340 shares at $5,035,000 based on the most recent closing price.

Stock Fundamentals for NUVB

Equity return is now at value -15.30, with -14.80 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 45.62.

Is CVS Health Corporation (CVS) a Keeper?

CVS Health Corporation (NYSE:CVS) went up by 0.55% from its latest closing price compared to the recent 1-year high of $111.25. The company’s stock price